Delivery Order SPE2DB20D3505-SPE2DB24FT3Z0
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,003.30, is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The award is a delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,505.97, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The contract is for the delivery of Lotrel 10-20 mg capsules, a cardiovascular medication, to support military healthcare...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,429.84, is a Firm Fixed Price Delivery Order contract for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of July 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, valued at $33,589.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $15,599.23 and has a completion date of September 22, 2023. It is a Firm Fixed Price contract for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract is part of a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,749.29 firm fixed-price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,105.51 firm fixed price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,030.63 Firm Fixed Price Delivery Order is for the supply of LOTREL 10-20 mg capsules, with a contract performance period ending on November 1, 2023. The award is not associated with a set-aside program. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $1,049.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,896.27 Firm Fixed Price delivery order is for the supply of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB24FT3Z0Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,286.73, is for the delivery of LOTREL 10-20 MG CAPSULE 100S, a cardiovascular medication. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award is likely part of that broader IDC contract. As a major distributor of medical products to federal government agencies, including the military and veterans' healthcare systems, Amerisourcebergen plays a critical role in ensuring the availability of essential pharmaceuticals and medical supplies for federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 11/28/23 |